Skip to content

Iguratimod

Drug profile

Also known as: careram, kolbet, T-614

PMDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Iguratimod is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2012. DrugCentral lists 1 molecular target, including MIF. Recorded indications include Rheumatoid arthritis.

  • Molecular targets: MIF (1 listed in DrugCentral).
  • Indications: Rheumatoid arthritis.
  • Molecular formula: C17H14N2O6S; molecular weight 374.37 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Rheumatoid arthritis

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Macrophage migration inhibitory factorMIFunknownIC50 5.17

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2012-06-29PMDA——

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Pneumocystis jirovecii pneumonia225.5
Interstitial lung disease203.5
Lymphoproliferative disorder171.2
Pneumonia bacterial92.7
Adult T-cell lymphoma/leukaemia60.6
Herpes zoster58.4
Varicella zoster pneumonia49.6
Osteonecrosis of jaw47.6
Diffuse large B-cell lymphoma44.7
Atypical mycobacterial infection37.9
Listeriosis37.8
Lymphoma34.7

Chemical structure

Molecular formulaC17H14N2O6S
Molecular weight374.37 g/mol
CAS number123663-49-0
InChIKeyANMATWQYLIFGOK-UHFFFAOYSA-N
PubChem CID124246
CS(=O)(=O)NC1=CC2=C(C=C1OC1=CC=CC=C1)C(=O)C(NC=O)=CO2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Iguratimod used for?

DrugCentral lists the following indications for Iguratimod: Rheumatoid arthritis.

How does Iguratimod work?

Its molecular targets in DrugCentral include MIF.

When was Iguratimod first approved?

Iguratimod was first approved by the PMDA in 2012.

What is the chemical formula of Iguratimod?

Iguratimod has the molecular formula C17H14N2O6S and a molecular weight of 374.37 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2012-06-29
AgencyPMDA
Targets1
Indications1
FormulaC17H14N2O6S
DrugCentral ID4894
Interactive profile